bioAffinity Technologies (BIAFW) Gains from Investment Securities (2021 - 2026)
bioAffinity Technologies (BIAFW) posted quarterly Gains from Investment Securities of $8432.0 for Q1 2026, down 97.23% YoY from $304125.0 in Q1 2025, and down 99.76% sequentially from $3.6 million in Q4 2025.
bioAffinity Technologies (BIAFW) Gains from Investment Securities (2021 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $8432.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 97.23% year-over-year to $8432.0; the TTM figure through Mar 2026 stood at $8432.0 (down 97.23% YoY), while the FY2025 annual figure was $9055.0, down 6.16% from the prior year.
- Gains from Investment Securities fell to $8432.0 in Q1 2026, from $3.6 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for BIAFW reached as high as $3.6 million in Q4 2025 and fell as low as -$252533.0 in Q4 2024.
- The 5-year median for Gains from Investment Securities is $86735.0 (2023), against an average of $436754.8.
- Annual changes were most pronounced in 2023 — Gains from Investment Securities jumped 37250.25% — and 2024, when it slumped 397.78%.
- A 5-year view of Gains from Investment Securities shows it stood at $26692.0 in 2022, then surged by 217.72% to $84805.0 in 2023, then tumbled by 397.78% to -$252533.0 in 2024, then surged by 1509.32% to $3.6 million in 2025, then plunged by 99.76% to $8432.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $8432.0, $3.6 million, and $9055.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | bioAffinity Technologies | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,174.00 |
| Mar 31, 2026 | 77,174.00 |
| Dec 31, 2025 | 3.56 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 9,055.00 |
| Sep 30, 2025 | 9,055.00 |
| Jun 30, 2025 | 92,975.00 |
| Jun 30, 2025 | 92,975.00 |
| Mar 31, 2025 | 304,125.00 |
| Mar 31, 2025 | 304,125.00 |
| Dec 31, 2024 | -252,533.00 |
| Dec 31, 2024 | -252,533.00 |
| Sep 30, 2024 | 91,038.00 |
| Sep 30, 2024 | 91,038.00 |
| Jun 30, 2024 | 152,982.00 |
| Jun 30, 2024 | 152,982.00 |
| Mar 31, 2024 | 88,665.00 |
| Mar 31, 2024 | 88,665.00 |
| Dec 31, 2023 | 84,805.00 |
| Dec 31, 2023 | 84,805.00 |